Scisparc Ltd. is a clinical-stage pharmaceutical company headquartered in Tel Aviv, Israel, specializing in the development of cannabinoid-based therapeutics. The company is committed to pioneering innovative treatments that harness the therapeutic properties of cannabinoids to address a range of medical conditions, thereby enhancing patient outcomes. Scisparc's strategic focus on research and development positions it as a leading player in the rapidly evolving cannabinoid pharmaceutical sector, aiming to leverage its cutting-edge drug development programs to capitalize on emerging opportunities in this market. Show more

Location: TOWER A, TEL AVIV, ISRAEL, 6971916, Tel Aviv, 6971916, USA | Website: https://scisparc.com | Industry: BIOTECHNOLOGY | Sector: HEALTHCARE